Ji Eun Shin

1.3k total citations
37 papers, 963 citations indexed

About

Ji Eun Shin is a scholar working on Obstetrics and Gynecology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Ji Eun Shin has authored 37 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 8 papers in Public Health, Environmental and Occupational Health and 8 papers in Immunology. Recurrent topics in Ji Eun Shin's work include Reproductive System and Pregnancy (8 papers), Pregnancy and preeclampsia studies (7 papers) and Ectopic Pregnancy Diagnosis and Management (5 papers). Ji Eun Shin is often cited by papers focused on Reproductive System and Pregnancy (8 papers), Pregnancy and preeclampsia studies (7 papers) and Ectopic Pregnancy Diagnosis and Management (5 papers). Ji Eun Shin collaborates with scholars based in South Korea, United States and Ethiopia. Ji Eun Shin's co-authors include Hyun Woo Park, Jae Hyung Park, Dong Hee Choi, Ji Hyang Kim, Hwang Kwon, Nam Keun Kim, Young Joo Jeon, HyungChul Rah, Young Myoung Moon and Sang Hoon Ahn and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Hepatology.

In The Last Decade

Ji Eun Shin

36 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji Eun Shin South Korea 17 258 243 232 185 183 37 963
Yu-Chih Wu Taiwan 13 355 1.4× 71 0.3× 103 0.4× 119 0.6× 25 0.1× 23 757
Lihua Sun China 18 231 0.9× 112 0.5× 32 0.1× 46 0.2× 46 0.3× 43 802
Souichi Yoshida Japan 16 196 0.8× 579 2.4× 100 0.4× 23 0.1× 478 2.6× 23 1.1k
Xiaoting Ma China 16 251 1.0× 95 0.4× 63 0.3× 19 0.1× 25 0.1× 58 734
Kim A. Butters United States 16 175 0.7× 77 0.3× 88 0.4× 124 0.7× 44 0.2× 24 612
Hanqin Lei United States 17 353 1.4× 204 0.8× 368 1.6× 6 0.0× 119 0.7× 22 980
Chih‐Ping Han Taiwan 15 271 1.1× 68 0.3× 125 0.5× 10 0.1× 108 0.6× 45 658
D.E. Clark United Kingdom 14 406 1.6× 434 1.8× 19 0.1× 23 0.1× 588 3.2× 16 1.0k
D. Djokovic Portugal 15 320 1.2× 101 0.4× 23 0.1× 8 0.0× 225 1.2× 37 756
Daniel Kahn United States 7 423 1.6× 557 2.3× 79 0.3× 10 0.1× 148 0.8× 10 1.1k

Countries citing papers authored by Ji Eun Shin

Since Specialization
Citations

This map shows the geographic impact of Ji Eun Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Eun Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Eun Shin more than expected).

Fields of papers citing papers by Ji Eun Shin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji Eun Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Eun Shin. The network helps show where Ji Eun Shin may publish in the future.

Co-authorship network of co-authors of Ji Eun Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Ji Eun Shin. A scholar is included among the top collaborators of Ji Eun Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji Eun Shin. Ji Eun Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shin, Ji Eun, Amir Khan, So Yeon Park, et al.. (2025). KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3+ blast phase chronic myeloid leukemia. Molecular Cancer. 24(1). 114–114. 1 indexed citations
3.
Huh, Hyunbin D., et al.. (2024). Reprogramming anchorage dependency to develop cell lines for recombinant protein expression. Biotechnology Journal. 19(5). e2400104–e2400104. 1 indexed citations
5.
Shin, Ji Eun, Soo‐Hyun Kim, Hwa-Ryeon Kim, et al.. (2023). Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia. Molecular Cancer. 22(1). 177–177. 12 indexed citations
6.
Shin, Ji Eun, Woochan Kim, Myeong‐Jin Kim, et al.. (2022). Discovery of indirubin-3′-aminooxy-acetamide derivatives as potent and selective FLT3/D835Y mutant kinase inhibitors for acute myeloid leukemia. European Journal of Medicinal Chemistry. 237. 114356–114356. 4 indexed citations
8.
Park, Jiyeon, Jiheon Kim, Hyo‐Jeong Lee, et al.. (2020). Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia. European Journal of Medicinal Chemistry. 195. 112205–112205. 28 indexed citations
9.
Kang, Sukho, et al.. (2019). Obstetrical outcomes of embryo reduction and fetal reduction compared to non-reduced twin pregnancies. Archives of Gynecology and Obstetrics. 299(4). 953–960. 3 indexed citations
10.
Shin, Ji Eun, et al.. (2019). Effect of Autologous Platelet-Rich Plasma Treatment on Refractory Thin Endometrium During the Frozen Embryo Transfer Cycle: A Pilot Study. Frontiers in Endocrinology. 10. 61–61. 100 indexed citations
11.
Shin, Ji‐Yeon, Kyoung‐Hee Sohn, Ji Eun Shin, et al.. (2018). Changing patterns of adult asthma incidence: results from the National Health Insurance Service–National Sample Cohort (NHIS-NSC) database in Korea. Scientific Reports. 8(1). 15052–15052. 20 indexed citations
12.
Jeong, Hye Seon, Hyon‐Jo Kwon, Hee‐Jung Song, et al.. (2014). Predictive Factors for Early Clinical Improvement after Intra-arterial Thrombolytic Therapy in Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 23(4). e283–e289. 12 indexed citations
13.
Jung, Yong Wook, Young Joo Jeon, HyungChul Rah, et al.. (2014). Genetic Variants in MicroRNA Machinery Genes Are Associate with Idiopathic Recurrent Pregnancy Loss Risk. PLoS ONE. 9(4). e95803–e95803. 34 indexed citations
14.
Kim, Ji Hyang, Young Joo Jeon, Boeun Lee, et al.. (2013). Association of methionine synthase and thymidylate synthase genetic polymorphisms with idiopathic recurrent pregnancy loss. Fertility and Sterility. 99(6). 1674–1680.e3. 29 indexed citations
15.
Jeon, Young Joo, Young Ran Kim, Bo Eun Lee, et al.. (2013). Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women. Thrombosis and Haemostasis. 110(10). 742–750. 28 indexed citations
16.
Lee, Boeun, Young Joo Jeon, Ji Eun Shin, et al.. (2012). Tumor Necrosis Factor-α Gene Polymorphisms in Korean Patients With Recurrent Spontaneous Abortion. Reproductive Sciences. 20(4). 408–413. 21 indexed citations
17.
Rah, HyungChul, Young Joo Jeon, Woo Sik Lee, et al.. (2012). Association of nitric oxide synthase gene polymorphisms (−786T>C, 4a4b, 894G>T) with primary ovarian insufficiency in Korean women. Maturitas. 74(2). 160–165. 6 indexed citations
18.
Kim, Ji Hyang, Ji Eun Shin, Youngsok Choi, et al.. (2011). Haplotype-based association of ACE I/D, AT1R 1166A>C, and AGT M235T polymorphisms in renin–angiotensin–aldosterone system genes in Korean women with idiopathic recurrent spontaneous abortions. European Journal of Obstetrics & Gynecology and Reproductive Biology. 158(2). 225–228. 24 indexed citations
19.
Jeon, Young Joo, HyungChul Rah, Dong Hee Choi, et al.. (2011). Association study of microRNA polymorphisms with risk of idiopathic recurrent spontaneous abortion in Korean women. Gene. 494(2). 168–173. 69 indexed citations
20.
Kim, Yoon Hee, et al.. (2010). Pretreatment with nafamostat mesilate, a kallikrein inhibitor, to decrease withdrawal response associated with rocuronium. Journal of Anesthesia. 24(4). 549–552. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026